Literature DB >> 27303061

The Effect of Undiagnosed Diabetes on the Association Between Self-Reported Diabetes and Cognitive Impairment Among Older Mexican Adults.

Brian Downer1, Amit Kumar2, Hemalkumar Mehta3, Soham Al Snih2, Rebeca Wong4.   

Abstract

PURPOSE: To study the effect of undiagnosed diabetes on the relationship between self-reported diabetes and cognitive impairment.
METHODS: Data were from 1033 participants aged ≥60 from Wave III (2012) of the Mexican Health and Aging Study. Participants were classified as nondiabetic (n = 589), undiagnosed diabetic (n = 201), and self-reported diabetic (n = 243). Multivariate logistic regression models were used to estimate the relationship between self-reported diabetes and severity of cognitive impairment (nonimpaired, moderate impaired, severe impaired).
RESULTS: Self-reported diabetes was associated with significantly higher odds for severe, but not moderate, cognitive impairment (odds ratio [OR] = 2.70, 95% confidence interval [CI] = 1.39-5.32). The association between self-reported diabetes and severe cognitive impairment decreased by 6.3% when undiagnosed diabetics were included in the nondiabetic category and by 30.4% when undiagnosed diabetics were included in the self-reported diabetes category. DISCUSSION: The association between self-reported diabetes and severe cognitive impairment is underestimated when undiagnosed diabetics are not differentiated from self-reported diabetics and nondiabetics.
© The Author(s) 2016.

Entities:  

Keywords:  Mexico; cognition; dementia; diabetes; older adults

Mesh:

Year:  2016        PMID: 27303061      PMCID: PMC5061627          DOI: 10.1177/1533317516653824

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  26 in total

1.  Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study.

Authors:  Wayne Katon; Courtney R Lyles; Melissa M Parker; Andrew J Karter; Elbert S Huang; Rachel A Whitmer
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies.

Authors:  G Cheng; C Huang; H Deng; H Wang
Journal:  Intern Med J       Date:  2012-05       Impact factor: 2.048

3.  Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study.

Authors:  Silvia Mejia-Arango; Luis Miguel Gutierrez
Journal:  J Aging Health       Date:  2011-10

4.  Using binary logistic regression models for ordinal data with non-proportional odds.

Authors:  R Bender; U Grouven
Journal:  J Clin Epidemiol       Date:  1998-10       Impact factor: 6.437

5.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

6.  A revised CES-D measure of depressive symptoms and a DSM-based measure of major depressive episodes in the elderly.

Authors:  C L Turvey; R B Wallace; R Herzog
Journal:  Int Psychogeriatr       Date:  1999-06       Impact factor: 3.878

7.  Does type 2 diabetes increase rate of cognitive decline in older Mexican Americans?

Authors:  Elizabeth R Mayeda; Mary N Haan; Kristine Yaffe; Alka M Kanaya; John Neuhaus
Journal:  Alzheimer Dis Assoc Disord       Date:  2015 Jul-Sep       Impact factor: 2.703

8.  Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence.

Authors:  James P Boyle; Theodore J Thompson; Edward W Gregg; Lawrence E Barker; David F Williamson
Journal:  Popul Health Metr       Date:  2010-10-22

9.  Uncontrolled diabetes increases the risk of Alzheimer's disease: a population-based cohort study.

Authors:  W L Xu; E von Strauss; C X Qiu; B Winblad; L Fratiglioni
Journal:  Diabetologia       Date:  2009-03-12       Impact factor: 10.122

10.  Type 2 diabetes and 10-year risk of dementia and cognitive impairment among older Mexican Americans.

Authors:  Elizabeth R Mayeda; Mary N Haan; Alka M Kanaya; Kristine Yaffe; John Neuhaus
Journal:  Diabetes Care       Date:  2013-03-20       Impact factor: 19.112

View more
  6 in total

1.  Midlife Vascular Factors and Prevalence of Mild Cognitive Impairment in Late-Life in Mexico.

Authors:  Miguel Arce Rentería; Jennifer J Manly; Jet M J Vonk; Silvia Mejia Arango; Alejandra Michaels Obregon; Rafael Samper-Ternent; Rebeca Wong; Sandra Barral; Giuseppe Tosto
Journal:  J Int Neuropsychol Soc       Date:  2021-08-11       Impact factor: 2.892

2.  Effects of diabetes and obesity on cognitive impairment and mortality in older mexicans.

Authors:  Sadaf Arefi Milani; David S Lopez; Brian Downer; Rafael Samper-Ternent; Rebeca Wong
Journal:  Arch Gerontol Geriatr       Date:  2021-11-17       Impact factor: 3.250

3.  The association between undiagnosed diabetes and cognitive function: findings from the China health and retirement longitudinal study.

Authors:  Jiafei Yang; Haiming Xu; Jiangping Li; Yu Zhao; Suzhen Guan; Youjuan Fu; Rui Bao; Zhihong Liu
Journal:  BMC Endocr Disord       Date:  2022-06-04       Impact factor: 3.263

4.  Association of Hypoglycemia With Subsequent Dementia in Older Patients With Type 2 Diabetes Mellitus.

Authors:  Hemalkumar B Mehta; Vinay Mehta; James S Goodwin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-08-01       Impact factor: 6.053

5.  Effect of Demographic and Health Dynamics on Cognitive Status in Mexico between 2001 and 2015: Evidence from the Mexican Health and Aging Study.

Authors:  Silvia Mejia-Arango; Jaqueline Avila; Brian Downer; Marc A Garcia; Alejandra Michaels-Obregon; Joseph L Saenz; Rafael Samper-Ternent; Rebeca Wong
Journal:  Geriatrics (Basel)       Date:  2021-06-25

6.  Social, behavioural, and functional characteristics of community-dwelling South Korean adults with moderate and severe cognitive impairment.

Authors:  Sanghun Nam; Brian Downer; Suyeong Bae; Ickpyo Hong
Journal:  Int J Methods Psychiatr Res       Date:  2022-03-12       Impact factor: 4.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.